Department of Obstetrics, University Magna Graecia of Catanzaro, Catanzaro, Italy.
J Minim Invasive Gynecol. 2010 Mar-Apr;17(2):192-9. doi: 10.1016/j.jmig.2009.11.009.
To evaluate the effectiveness of the Gynecare Morcellex tissue morcellator (Ethicon, Inc., Somerville, NJ) in laparoscopic supracervical hysterectomy and myomectomy.
Randomized controlled trial (Evidence I).
University department of obstetrics and gynecology.
Seventy-four patients with symptomatic uterine myomas scheduled for laparoscopic supracervical hysterectomy or myomectomy.
Laparoscopic supracervical hysterectomy and myomectomy followed by tissue morcellation using the Gynecare Morcellex (experimental group) or the Rotocut G1 morcellator (Karl Storz GmbH & Co. KG, Tuttlingen, Germany) (control group).
Patient characteristics and surgical data were noted for both groups. No difference was detected between groups in any parameters assessed, whereas a significant difference (p <.05) in handling score was detected in the experimental group compared with the control group.
The Gynecare Morcellex is an effective instrument with excellent safety and handling.
评估 Gynecare Morcellex 组织切碎器（Ethicon，Inc.，Somerville，NJ）在腹腔镜子宫颈上切除术和子宫肌瘤切除术的有效性。
随机对照试验（证据 I）。
妇产科大学系。
74 名患有症状性子宫肌瘤的患者，计划行腹腔镜子宫颈上切除术或子宫肌瘤切除术。
腹腔镜子宫颈上切除术和子宫肌瘤切除术，然后使用 Gynecare Morcellex（实验组）或 Rotocut G1 切碎器（Karl Storz GmbH & Co. KG，Tuttlingen，德国）（对照组）进行组织切碎。
记录了两组患者的特征和手术数据。在评估的所有参数方面，两组之间均未发现差异，而实验组的操作评分与对照组相比存在显著差异（p <.05）。
Gynecare Morcellex 是一种有效、安全且易于操作的器械。
Zotero 插件